Cargando…
Liver damage favors the eliminations of HBV integration and clonal hepatocytes in chronic hepatitis B
BACKGROUND: HBV integration is suspected to be an obstinate risk factor for hepatocellular carcinoma (HCC) in the era of antiviral therapy. Integration events start to occur in the immunotolerance phase, but their fates in the immune clearance phase have not yet been clarified. Here, we report the i...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer India
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886763/ https://www.ncbi.nlm.nih.gov/pubmed/33534083 http://dx.doi.org/10.1007/s12072-020-10125-y |